Atlas Trials

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling)

Clinical trial NCT03493581 · UNKNOWN

Trial details

NCT number
NCT03493581
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Patients
Start date
2018-03-08
Primary completion
2024-03-08
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.